Literature DB >> 22129221

Unusual combination of holt-oram syndrome and persistent left superior vena cava.

Sergio Thal1, Ravichandra Boyella, Reza Arsanjani, Hoang Thai, Elizabeth Juneman, Mohammad Reza Movahed, Steven Goldman.   

Abstract

UNLABELLED: Holt-Oram (HO) is a syndrome characterized by congenital cardiovascular malformations, specifically atrial and ventricular septal defects, and skeletal abnormalities of the upper limbs bones. Associations of HO cardiac disorders with other congenital cardiac malformations, specifically persistent left superior vena cava (PLSVC) are rarely reported and its real incidence is unknown. We present a case of this unusual combination in a patient undergoing cardiac resynchronization therapy (CRT) device implant. METHODS AND
RESULTS: A 63-year-old male with HO and a history of repaired atrial septal defect was presented for implantable cardioverter defibrillator (ICD) upgrade to CRT. The old implant was located in the right prepectoral area. The old device pocket in the right was accessed and a venous access to the right subclavian vein was obtained. The coronary sinus (CS) was easily cannulated and a long sheath advanced into the CS. A contrast injection revealed an unusually big-sized CS, with a diameter 2.5 times the fully deployed balloon. A 0.035 wire was advanced retrograde reaching the confluence of the innominate and left subclavian veins. The outer sheath was advanced to this location and contrast venography through the sheath allowed visualization of the left jugular and subclavian veins and visualization of the PLSVC draining into the CS. No target veins for lead implant were identified. The patient was referred for surgical implant of an epicardial lead. Transesophageal echocardiogram showed a CS identified as an unusually big vascular structure located between the left atrium and the left atrial appendage.
CONCLUSION: We report an uncommon association of HO and PLSVC. This association was only reported twice in the past and this is the first one that constitutes a casual finding during the attempt of CRT device implant. This is a combination that may complicate a device implant and recognition of it in advance may avoid performing potentially unsuccessful procedures.
© 2011 Copyright the Authors. Congenital Heart Disease © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22129221     DOI: 10.1111/j.1747-0803.2011.00594.x

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  5 in total

1.  Retaining of PTCA guide wire in the left ventricular lead and subsequent application of epicardial electrode when CRT-D implantation in a patient with severe heart failure and persistent left superior vena cava: a case report.

Authors:  Pei-Pei Hou; Yu-Hong Liu; Hai-Bo Qu; Jin Meng; Qiang Li; Zhi-Lin Miao
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 2.  Tetralogy of Fallot with Holt-Oram syndrome: case report and review.

Authors:  Abhay Tidake; Pranil Gangurde; Zohaib Shaikh; Ajay Mahajan
Journal:  Clin Res Cardiol       Date:  2015-04-23       Impact factor: 5.460

Review 3.  Insights into the genetic structure of congenital heart disease from human and murine studies on monogenic disorders.

Authors:  Terence Prendiville; Patrick Y Jay; William T Pu
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-01       Impact factor: 6.915

4.  Persistent left superior vena cava in cardiac congenital surgery.

Authors:  Cristina Giuliani-Poncini; Marie-Hélène Perez; Jacques Cotting; Michel Hurni; Nicole Sekarski; Jean-Pierre Pfammatter; Stefano Di Bernardo
Journal:  Pediatr Cardiol       Date:  2013-07-03       Impact factor: 1.655

5.  Diversity of congenital cardiac defects and skeletal deformities associated with the Holt-Oram syndrome.

Authors:  Gregory Chryssostomidis; Meletios Kanakis; Vassiliki Fotiadou; Cleo Laskari; Theofili Kousi; Christos Apostolidis; Prodromos Azariadis; Andrew Chatzis
Journal:  Int J Surg Case Rep       Date:  2014-05-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.